z-logo
Premium
Right foot congenital infantile fibrosarcoma treated only with chemotherapy
Author(s) -
Demir Hacı Ahmet,
Akyüz Canan,
Varan Ali,
Ergen Fatma Bilge,
Büyükpamukçu Münevver
Publication year - 2010
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.22389
Subject(s) - medicine , disarticulation , foot (prosody) , fibrosarcoma , amputation , blood cancer , chemotherapy , surgery , metatarsal bones , cancer , pathology , linguistics , philosophy
Congenital infantile fibrosarcoma (CIF) is a rare tumor in childhood. The 5‐year survival rate for CIFs is high and has been reported between 84% and 93%, but limb‐amputation/disarticulation is still a major problem. We report the case of a male newborn with a mass in his right foot. X‐ray and MRI revealed a mass destroying all tarsal, metatarsal, and phalangeal bones. The patient was treated only with VAC chemotherapy and is able to walk normally. Pediatr Blood Cancer 2010;54:618–620. © 2009 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom